Tickwind
TodayOpportunitiesMarketsAI Chat
EN
Log inSign up
Tickwind

Read every tick. See where the market's blowing.

  • X
  • TelegramChinese
  • Newsletter

Product

  • Markets
  • Theme Zones
  • All stocks
  • Compare
  • Hot stocks
  • Opportunities
  • News
  • Discussion
  • Watchlist
  • What's new

Account

  • Settings
  • Newsletter
  • For writers
  • MCP server
  • Contact
  • Log in
  • Sign up
MarketsTheme ZonesAll stocksCompareHot stocksOpportunitiesNewsDiscussionWatchlistWhat's newSettingsNewsletterFor writersMCP serverContactLog inSign up

© 2026 Tickwind. Not investment advice.

Made for the curious investor.

Home/GTBP/Revenue

GT Biopharma, Inc. (GTBP) Revenue 2016–2020

GT Biopharma, Inc. (GTBP) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.

$0FY2020 · since FY2016: $0 → $0
16171920
Fiscal yearValueYoY
FY2020$0—
FY2019$0—
FY2017$0—
FY2016$0—

Source: SEC XBRL filings · For reference only · Not investment advice

More GTBP financial trends

GTBP Net incomeGTBP Net marginGTBP Gross profitGTBP Gross marginGTBP Operating incomeGTBP Operating marginGTBP Operating cash flowGTBP Free cash flowGTBP Capital expendituresGTBP Return on equityGTBP Stock buybacksGTBP Dividends paidGTBP Total assetsGTBP Total liabilitiesGTBP Shareholders’ equityGTBP overview →